B7-like molecules and uses thereof

Details for Australian Patent Application No. 2001271618 (hide)

Owner Amgen Inc.

Inventors Sarmiento, Ulla M.; Chute, Hilary T.; Welcher, Andrew A; Schultz, Henry J.

Agent Wrays

Pub. Number AU-B-2001271618

PCT Pub. Number WO02/00710

Priority 09/729,264 28.11.00 US; 60/214,512 28.06.00 US

Filing date 28 June 2001

Wipo publication date 8 January 2002

Acceptance publication date 22 December 2005

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

22 December 2005 Application Accepted

  Published as AU-B-2001271618

27 April 2006 Standard Patent Sealed

27 April 2006 Corrigenda

  Applications Accepted - Name Index Under the name Amgen Inc., Application No. 2001271618, under INID (71) correct the name to read Amgen, Inc.

29 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001271619-7, 9-substituted tetracycline compounds

2001271617